510(k) Report

510(k) · Cleared

Cleared

Lancing Device (PressGo, LDE3, LDE3AST, LDE5, EasyStep)

K260122510(k) TraditionalCleared Jul 6, 2026172-day reviewClass II21 CFR 878.4850

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

SteriLance Medical (Suzhou), Inc. · QRL Multiple Use Blood Lancet For Single Patient Use Only

Cleared on Jul 6, 2026 as substantially equivalent to K221970 (SteriLance Medical (Suzhou), Inc., 2022) after a 172-day review. Its family tree reaches back 4 generations to 2000.

Decided
Jul 6, 2026
Review
172 days
Class
Class II
Product code
QRL
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K002134 (2000). No later device cites it as a predicate yet.

  1. Root · 4 generations backK002134 One Touch Ultra Blood Glucose Monitoring SystemSelfcare, Inc. · 2000
  2. 3 generations backK090057 ON-Call Plus Blood Glucose Monitoring SystemAcon Laboratories Co. · 2009
  3. 2 generations backK113332 ON Call Chosen Lancing DeviceACON Laboratories, Inc. · 2012
  4. 1 generation backK221970 Lancing deviceSteriLance Medical (Suzhou), Inc. · 2022
  5. This deviceK260122 Lancing Device (PressGo, LDE3, LDE3AST, LDE5, EasyStep)SteriLance Medical (Suzhou), Inc. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K002134One Touch Ultra Blood Glucose Monitoring SystemSelfcare, Inc.2000—
−3K090057ON-Call Plus Blood Glucose Monitoring SystemAcon Laboratories Co.2009—
−2K113332ON Call Chosen Lancing DeviceACON Laboratories, Inc.2012—
−1K221970Lancing deviceSteriLance Medical (Suzhou), Inc.2022—
0 (this device)K260122Lancing Device (PressGo, LDE3, LDE3AST, LDE5, EasyStep)SteriLance Medical (Suzhou), Inc.2026—
FIG. 1 — Lineage of K260122, 2000–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QRL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QRL device

  1. #1 K214022 Accu-Chek Softclix Blood Lancing Systemscore 38.9 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K221970Lancing device
Summary page 5
…Traditional 510(k) 3. Predicate Device SteriLance Medical (Suzhou) Inc., LDE; LDE AST; LDE4; LDE4 AST; NanoSense; OneStep Lancing Device, under K221970. 4. Device Description Lancing device is used with disposable blood lancet to obtain capillary blood samples. It…
SteriLance Medical (Suzhou), Inc.2022—

Also cleared against K221970: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 4 companies; a new generation was cleared every 8.7 years on median.
  • None of the 4 ancestors has a recall.
  • 1 other device also cites its predicate K221970.

How does its category compare?

All QRL devices

QRL Multiple Use Blood Lancet For Single Patient Use Only: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · QRL

2in 2025

2022: 172023: 32024: 22025: 22026 (partial year): 3
2007high 17 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QRL

155in 2023

2022: 91 days median2023: 155 days median2026 (partial year): 54 days median
2007high 155 (2023) · low 91 (2022)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QRL

1in 2025

2025: 1
2007high 1 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QRL

133in 2025

2022: 12023: 32024: 72025: 133
2007high 133 (2025) · low 0 (2007)2025

MAUDE reports naming product code QRL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
2022179101
2023315503
20242—07
20252—1133
20263540—

What is it indicated for?

Lancing device is used with disposable blood lancet to obtain capillary blood samples.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K260122: Lancing Device (PressGo, LDE3, LDE3AST, LDE5, EasyStep).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K260122

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026